Post on 21-Dec-2015
Agenda
About Novartis1.
Novartis Germany2.
Areas of responsibilities3.
External lawyers• Why do we mandate?
• How does success look like?
4.
2 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Agenda
About Novartis1.
Novartis Germany2.
Areas of responsibilities3.
External lawyers• Why do we mandate?
• How does success look like?
4.
3 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
„Caring and Curing“ as mission statement
Net sales: USD 50,6 Billion
Employees: 119.000
Local entities: 140
Headquarter: Basel
2010 Data Novartis International
4 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
4 Divisions & singular range of products
Generika – Sandoz/Hexal
Novartis Pharma
Novartis Vaccines
Consumer HealthOTC / Animal Health / CIBA VISION
5 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Strong performance in all business areas
Sales by segment – 2010 Sales by region – 2010
Company overview
Employees 119 418
Countries 140
Headquarters Basel, Switzerland
2010 USD billion
Net sales 50.6
Net income 10.0
R&D investment 8.1
Key facts
Canada/Latin America
US
Europe
Asia/Africa/Australasia
Alcon, Inc.1
1 Regional data for Alcon, Inc. not available
Sandoz
Pharmaceuticals
Vaccines andDiagnostics
Consumer Health
Alcon, Inc.
6 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Agenda
About Novartis1.
Novartis Germany2.
Areas of responsibilities3.
External lawyers• Why do we mandate?
• How does success look like?
4.
7 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
About 8.000 employees* on 14 facilities in Germany
Sandoz Hexal Hauptverwaltung
Novartis Vaccines Holzkirchen
Hexal Aeropharm Produktion Rudolstadt
Sandoz Hexal Produktion Barleben bei Magdeburg
Novartis PharmaNovartis HoldingWehr
Consumer HealthTiergesundheit München
Novartis PharmaNürnberg
CIBA VISION Großwallstadt
CIBA VISIONGroßostheim
Salutas Pharma Gerlingen
Sandoz Industrial Products Frankfurt
Jenahexal Produktion Jena
Novartis Vaccines Marburg
Facility> 600 Employees
1 A Pharma Oberhaching
NeocorpWeilheim
* FTEs (=full-time employment-
equivalence)
Alcon Pharma GmbHFreiburg
8 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Novartis-Group on the top in Germany
Gross Sales in Billion Euro*
+ 1,6 %
2009 2010
3,093.04
PFIZER
SANOFI AVENTIS
BAYER
KOHL MEDICAL AG
ROCHE
BOEHRINGER
ABBOTT
** Quelle: IMS; Total Market (DPM+Hospital)
ASTRA ZENECA
NOVARTIS
GSK
TEVA
MSD
Market Share in %** (YTD 12/2010)
9 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
People – Organizational Chart Legal & Compliance & BD & L
Country Legal Head GermanyMartin Eschbach
Head Legal, BD&L,New Products and Compliance
Martin Eschbach
LawyerE. Meuthen-Kuhnen
Lawyer J.-H. Petersen
LawyerS. Uher
LawyerA. Zierenberg
LawyerF. Zimmermann (0.5)
BD&LS. Werner
BD&LJ. Schwager
New ProductsC. Fritsch/
J. Zimmermann
Legal CoordinatorJ. Woell
Head Legal,Compliance Officer
Stefan Ibing
Head Legal,Compliance Officer
Alexander Meier
LawyerG. Keck
LawyerA. Melzer (0.7)
LawyerS. Stutz
Legal Advisor
Frank Kaul
Legal Director
GrahamWilkinson
Sandoz/Hexal Vacc. & Diagn.
= Functional report
= Direct report
Compliance K. Michel (0.5)
Ciba Vision OTC/Animal Health
PharmaConsumer Health
LawyerS. Balendran
(Name) = Assistant
Compl. OfficerU. GüllandLawyer
C. Ullmann
10 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Agenda
About Novartis1.
Novartis Germany2.
Areas of responsibilities3.
External lawyers• Why do we mandate?
• How does success look like?
4.
11 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Responsibilities - departements (1/2)
• Respiratory System/Dermatology/Allergology
• Business Development & Licensing
• Controlling
• Chief Executive Officer and Managing Directors
• Communications
• Demand Managemenet
• Drug Regulatory Affairs
• Drug Safety
• Financial Reporting and Accounting
• Human Resources
• Health and Safety Executive
• Internet
• Key Account Management
• Market Access
• Medical (Medical Competence Center)
• Purchasing
• Strategic Planning and Projects
• Travel & Event Management
12 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Responsibilities - topics (2/2)
• Tender Law
• Insurance
• Competition Law
• Anticorruption
• Labour Law
• Narcotics
• Compliance
• Data Privacy
• Industrial Property Rights
• Information Security Officer
• Anti-Trust Law
• Knowledge Management
• Social Law
• Copyright
13 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Agenda
About Novartis1.
Novartis Germany2.
Areas of responsibilities3.
External lawyers• Why do we mandate?
• How does success look like?
4.
14 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Outside Counsel PanelExternal Lawyers
15 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
1. Account responsibility and global relationship
2. Engagement
3. Staffing
4. Conflicts of interest
5. Corporate citizenship
6. Relationship with responsible Novartis contacts
7. Communication with the press
8. Fees, special fee arrangements and work plans1. Fees
2. Special fee arrangements
3. Work plans and budgets
9. Disbursements
10. Bills and supporting information
External lawyers Terms of engagement (1/2)
16 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
11. Contacts with public officials
12. Security of communication and protection of information
13. Data protection, electronic communications and document retention 1. Data protection
2. Electronic communications
3. Document retention
14. Liability 1. Liability with other parties
2. Liability for undisclosed agents
3. Limitations on exclusions
15. Claims 1. Claims by us
2. Resolving claims
16. Taxes, duties and exchange controls
17. Application of laws or regulations
External lawyers Terms of engagement (2/2)
17 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
Why do we mandate external counsels?
Special know-how eg., anti-trust, M & A, labour law
Pan-European project eg., out-sourcing, IP-matters
„Bread & Butter“ contracts & business, eg. medical/study
agreements
External lawyers
18 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only
External lawyers
How does success look like?
Cost/benefit analysis
Tangible value add (templates, training-material, contracts)
Trust building exercise (long term relationship)
Reasonable billing
19 | Parlex Conference | Martin Eschbach | 20 May 2011 | Engaging external lawyers | Business Use Only